Debevoise is a leading international firm whose lawyers work on some of the most important headline matters of the day. The firm was built on the bedrock principle of superior client service, the kind of service that can only be delivered by commercially savvy, ambitious lawyers on whom leading global enterprises rely for their most complex and important deals and matters.
With more than 600 lawyers in nine offices located in New York, Washington, D.C., London, Paris, Frankfurt, Moscow, Hong Kong, Shanghai, and Tokyo, we are well versed in the increasingly global issues facing our healthcare and life sciences clients.
Debevoise combines a laser-like focus on client objectives, with deep transactional and litigation experience across a wide range of sectors in the healthcare and life sciences industries. Our Healthcare and Life Sciences Group employs a highly coordinated, multidisciplinary approach to address transactional, litigation and intellectual property matters for leading healthcare and life sciences companies and their investors. The Group draws from a broad array of practices throughout the firm, leveraging its experience in private equity, M&A, finance, capital markets, restructuring, litigation, government and regulatory investigations, tax, intellectual property and antitrust, among others.
The team provides integrated, cross-practice legal advice with efficient and seamless execution covering all aspects of healthcare matters, including corporate and M&A, litigation and compliance, FDA/FTC regulatory, intellectual property, including licensing and collaboration agreements, and cybersecurity & data privacy. The group's transactional work includes mergers and acquisitions, financings, securities offerings, licensing, development and commercialization transactions. Debevoise lawyers are the long-time editors and contributors to the Healthcare Mergers and Acquisitions Answer Book (Practising Law Institute, 2018), an extensive reference guide, published yearly, addressing structuring, regulatory, due diligence and documentation issues in healthcare M&A and licensing transactions.
The litigation and enforcement practices advise on bet-the-company litigation, government and internal investigations and help navigate clients through complex civil matters, intellectual property issues, advertising disputes, and international dispute resolution. Debevoise lawyers also regularly counsel healthcare clients regarding compliance programs, preventive measures and assist with the collateral consequences that may arise from criminal proceedings. The group also routinely represents board committees conducting independent investigations and compliance reviews.
We are proud to offer cutting-edge transactional advice and broad litigation and regulatory experience that allow our clients to successfully complete deals, conclude enforcement actions, resolve disputes and implement industry-leading compliance programs. We are also extremely pleased that Debevoise partners Andrew L. Bab, Mark P. Goodman, Kevin Rinker, Paul D. Rubin and Edwin Schallert have been recognized as "Life Sciences Stars" in the LMG Life Sciences 2018 Guide.
